Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 9 | 2025 | 276 | 3.720 |
Why?
|
| Liver | 10 | 2023 | 1749 | 2.110 |
Why?
|
| Circadian Clocks | 4 | 2023 | 59 | 1.690 |
Why?
|
| Gene Expression Regulation | 7 | 2025 | 2524 | 1.240 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 4 | 2023 | 21 | 1.180 |
Why?
|
| Quantitative Trait Loci | 1 | 2025 | 287 | 0.860 |
Why?
|
| Hepatocytes | 3 | 2023 | 210 | 0.850 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2023 | 27 | 0.800 |
Why?
|
| Genetic Variation | 2 | 2025 | 1505 | 0.690 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 118 | 0.670 |
Why?
|
| Professional Misconduct | 1 | 2019 | 35 | 0.650 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2019 | 68 | 0.610 |
Why?
|
| PPAR alpha | 1 | 2018 | 51 | 0.590 |
Why?
|
| Lipogenesis | 4 | 2023 | 56 | 0.530 |
Why?
|
| Feeding Behavior | 2 | 2020 | 699 | 0.480 |
Why?
|
| Lipid Metabolism | 4 | 2025 | 357 | 0.450 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2025 | 3175 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 1271 | 0.410 |
Why?
|
| Diet | 1 | 2018 | 1139 | 0.360 |
Why?
|
| Mice | 12 | 2025 | 17743 | 0.290 |
Why?
|
| Obesity | 1 | 2018 | 2251 | 0.270 |
Why?
|
| Animals | 13 | 2025 | 34309 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 6 | 2023 | 4420 | 0.260 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2025 | 14 | 0.240 |
Why?
|
| Adipocytes | 3 | 2022 | 141 | 0.230 |
Why?
|
| Acetate-CoA Ligase | 1 | 2023 | 4 | 0.220 |
Why?
|
| Physical Conditioning, Animal | 1 | 2025 | 93 | 0.220 |
Why?
|
| Transcriptome | 3 | 2025 | 977 | 0.220 |
Why?
|
| Thiazolidinediones | 1 | 2022 | 82 | 0.180 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2021 | 8 | 0.180 |
Why?
|
| Gene Expression | 2 | 2023 | 1554 | 0.180 |
Why?
|
| RNA, Small Untranslated | 1 | 2021 | 21 | 0.180 |
Why?
|
| Epigenomics | 1 | 2021 | 176 | 0.170 |
Why?
|
| Cell Communication | 1 | 2020 | 167 | 0.160 |
Why?
|
| Gene Deletion | 2 | 2020 | 793 | 0.160 |
Why?
|
| Fatty Liver | 2 | 2018 | 190 | 0.160 |
Why?
|
| Kidney Diseases | 1 | 2023 | 485 | 0.160 |
Why?
|
| Hippocampus | 1 | 2025 | 825 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 298 | 0.160 |
Why?
|
| Genotype | 1 | 2025 | 2569 | 0.160 |
Why?
|
| RNA | 1 | 2022 | 574 | 0.150 |
Why?
|
| Communication | 1 | 2023 | 515 | 0.150 |
Why?
|
| Glucocorticoids | 1 | 2021 | 384 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2025 | 2652 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 371 | 0.150 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 403 | 0.140 |
Why?
|
| Light | 1 | 2018 | 176 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 798 | 0.140 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2017 | 18 | 0.140 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2017 | 10 | 0.140 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 376 | 0.140 |
Why?
|
| Insulin Resistance | 1 | 2022 | 642 | 0.130 |
Why?
|
| Genome | 1 | 2019 | 481 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2016 | 2 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2019 | 465 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2020 | 826 | 0.120 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 443 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 2061 | 0.110 |
Why?
|
| Stem Cells | 1 | 2019 | 709 | 0.110 |
Why?
|
| Mice, Knockout | 1 | 2020 | 3753 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2018 | 855 | 0.090 |
Why?
|
| Humans | 7 | 2025 | 125466 | 0.090 |
Why?
|
| PPAR gamma | 2 | 2022 | 88 | 0.080 |
Why?
|
| Male | 4 | 2025 | 61637 | 0.080 |
Why?
|
| Gene Knockout Techniques | 2 | 2017 | 126 | 0.070 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2025 | 126 | 0.060 |
Why?
|
| Kidney Tubules | 1 | 2023 | 78 | 0.050 |
Why?
|
| Protein Binding | 2 | 2019 | 1755 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2025 | 283 | 0.050 |
Why?
|
| Fibrosis | 1 | 2023 | 441 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2022 | 404 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2021 | 120 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2021 | 272 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 2414 | 0.040 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2019 | 19 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 292 | 0.040 |
Why?
|
| NFI Transcription Factors | 1 | 2019 | 50 | 0.040 |
Why?
|
| Female | 1 | 2025 | 66904 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2017 | 7 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2019 | 342 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1363 | 0.030 |
Why?
|
| Gene Editing | 1 | 2019 | 186 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 859 | 0.030 |
Why?
|
| Cholesterol | 1 | 2019 | 541 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 1446 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 486 | 0.030 |
Why?
|
| Motor Activity | 1 | 2018 | 521 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 4405 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 3109 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2018 | 1134 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2755 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2018 | 765 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 4595 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2017 | 1538 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 19747 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 26833 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 29642 | 0.010 |
Why?
|